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Abstract
Generating a diverse T-cell memory population through vaccination is a promising strategy to
overcome pathogen epitope variability and tolerance to tumor antigens. The effector and memory
pool becomes broad in TCR diversity by recruiting high and low affinity T-cells. We wanted to
determine which factors dictate whether a memory T-cell pool has a broad vs. focused repertoire.
We find that inflammation increases the magnitude of low and high affinity T-cell responses
equally well, arguing against a synergistic effect of TCR and inflammatory signals on T cell
expansion. We dissect the differential effects of TCR signal strength and inflammation and
demonstrate that they control effector T-cell survival in a bim-dependent manner. Importantly,
bim-dependent cell death is overcome with a high antigen dose in the context of an inflammatory
environment. Our data define the framework for the generation of a broad T-cell memory pool to
inform future vaccine design.
Introduction
During the course of an infection, antigen-specific CD8 T cells become activated, acquire
effector function and a fraction of these cells will then differentiate into long-lived memory
CD8 T cells (1–3). The generation of large numbers of high affinity T cells during this
process is generally considered a desirable and advantageous outcome as it selects for the
best responders. Recent studies have strongly suggested a significant biological role for low
affinity T cells in creating a successful vaccination strategy. CD8 T cells activated by low
affinity ligands are recruited into the primary CD8 T cell response as well as the ensuing
CD8 memory T cell pool (4). T cell mediated protection against pathogens that are capable
of a high mutation rate may benefit from a repertoire of antigen-specific T cells that is very
broad. A broad repertoire includes T cells which react only weakly to the initial priming
antigen (low affinity T cells), but may recognize subsequently mutated epitopes with high
affinity. Recent evidence from an HIV vaccine trial shows that the mere presence of
memory CD8 T cells is not enough to provide protection against HIV infection (5) and this
lack of protection could be attributed to insufficient potency or breadth of epitope
recognition (6). Importantly, previous animal studies indeed underline a crucial role for TCR
repertoire diversity to prevent viral escape mutants (7, 8). This protective benefit of a broad
T cell repertoire is presumably true for all highly variable pathogens whether they are
chronic infections such as described in the aforementioned studies or acute infections like
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influenza (9). Moreover, anti-tumor responses may depend on recruiting lower affinity T
cells since higher affinity T cells are often eliminated by tolerance mechanisms. The main
focus in the cancer immunotherapy field is on generating high numbers of functional CTLs
to eliminate tumor burden.
In the context of vaccine design it is a major challenge to trigger potent T cell responses and
the parameters that allow for induction of T cell responses with a broad repertoire are still
poorly understood. Historically, vaccines using live attenuated viruses such as the smallpox,
polio (Sabin) and yellow fever vaccine have been highly successful and shown to prime
long-lived, potent T cell responses (10–12). More recently, an SIV vaccine based on a
recombinant rhesus cytomegalovirus (RhCMV) provided protection against highly
pathogenic SIV (13). Two major differences between live and inactivated vaccines are the
amount of inflammation and antigen dose elicited by each vaccine, with live vectors
generating more potent inflammatory responses and presumably providing more antigen. It
has been established that TCR signal strength, antigen availability and inflammation are the
driving forces of the primary and memory T cell response (1–3, 14), but it is still unclear
how these signals interact to shape the breadth of the T cell response and affect high and low
affinity T cell responses (2, 14). Previous studies suggest that cytokine and TCR signals can
synergize to mediate memory CD4 T cell survival (15). Whether comparable synergistic
events take place in CD8 T cells is still unknown, but such an integration of different signals
could enhance the selective outgrowth of the highest affinity T cells and regulate affinity
maturation of the memory T cell pool (16). Gaining a more thorough understanding of the
mechanisms involved in efficient priming and survival of low affinity T cells is thus of
broad general interest in the context of infectious disease as well as cancer therapy.
The primary goal of this study is to address how inflammation, TCR signal strength and
antigen availability interact to shape the breadth and function of the effector and memory T
cell response. We used an experimental system, which gave us tight control over factors that
can vary between different vaccine formulations or types of infection. This system allowed
us demonstrate that (1) concurrent inflammation enhances effector T cell responses to the
same extent regardless of the strength of the TCR stimulus, (2) inflammation and TCR
signal strength control distinct and overlapping phenotypic and functional characteristics of
the effector cell population, (3) bim-mediated cell death is responsible for the loss of low
affinity effector cells under conditions of limited inflammation and antigen availability, but
(4) this can be overcome with increased antigen availability and inflammation.
Material and Methods
Mice
C57BL/6 (B6) and B6 congenic (CD45.1+ and Thy1.1+) mice were obtained from Jackson
Laboratory (Bar Harbor, ME) and housed in SPF conditions at the University of Washington
and the Fred Hutchinson Cancer Research Center (Seattle, WA). OT-I TCR transgenic mice
congenic for CD45.1 or Thy1.1 and bim−/− OT-I mice were bred and maintained in the same
facilities.
Adoptive transfer and cell sorting: naïve CD44low OT-I T cells were isolated from lymph
nodes by separation over a magnetic column (Miltenyi) as previously described (17). A total
number of 1×104 naïve OT-I T cells was transferred i.v. per recipient. This number was
chosen based on a 10% take of transferred cells in a new host following adoptive transfer
(17, 18) and a precursor frequency of antigen-specific, endogenous T cells that can range
from less than 102 to over 103 (19, 20).
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Dendritic cell isolation
Dendritic cells (DC) were expanded in B6 mice with a Flt3L secreting cell line (B16-Flt3L).
10–14 days after injection of the B16-Flt3L cells CD11c+ cells were purified, LPS (1μg/ml)
and peptide (1μg/ml) pulsed in vitro for 1 hour (37°C) prior transfer as previously described
(17). A total number of 1×106 DCs was transferred i.v. per recipient.
Infections
Listeria monocytogenes was grown as previously described (17). For primary infections,
mice were injected i.v. with 2×103 cfu LM. In some experiments memory cells were boosted
with a recombinant VSV strain expressing the SIINFEKL epitope (21) or a recombinant
vaccinia strain expressing the SIINFEKL epitope (22) and were sacrificed 5 to 7 days later
(2×106 pfu, i.v., in each case).
Flow Cytometry
Recipient mice were sacrificed at the time points indicated. For intracellular staining, cells
were prepared with the Cytofix/Cytoperm kit in the presence of brefeldin A (BD) and
incubated with or without 100nM SIINFEKL peptide for 4–5 hours in RP10. Cells were
analyzed using a FACSCanto (BD) and FlowJo (TreeStar) software.
Results
Inflammation enhances generation of CD8 effector cells
We first addressed whether cytokine signals synergize with the strength of a TCR signal. For
this purpose we relied on the OT-I system to provide defined TCR specificity. OT-I T cells
are activated by the high affinity SIINFEKL (N4) peptide of chicken ovalbumin (OVA)
presented by H2-Kb (23). A large number of altered peptide ligands (APLs) with equal
ability to bind to H-2Kb but gradually reduced TCR affinity have been described which
nevertheless all still activate OT-I T cells (4). We decided to use the low affinity APL
SIIQFEKL (Q4) for this study, because it elicits an OT-I T cell response that can still be
easily measured and it is well above the threshold of thymic negative selection (24, 25). In
order to keep antigen dose and availability constant, we used a system where antigen is
provided by ex vivo isolated (from B16-Flt3L injected animals), LPS activated, peptide
pulsed DCs and inflammation is provided by a concurrent infection with wild-type Listeria
monocytogenes (LM) that does not provide antigen for the OT-I T cells (17, 26). A small
number of naïve OT-I T cells was transferred into recipient mice together with high (N4) or
low (Q4) affinity antigen pulsed DCs. In the presence of an accompanying LM infection N4
pulsed DCs generated an approx. 2 to 3-fold bigger OT-I effector population compared to
the peptide pulsed DC only group in the blood (Fig. 1A) and spleen (Fig. 1B) on day 5.
Interestingly, a similar enhancement by bystander Listeria infection was observed for Q4
stimulated OT-I T cells (Fig. 1A, B). We chose day 5 as a time-point to examine OT-I T cell
phenotype and function after the expansion stage was completed in both (N4 and Q4
primed) conditions (Fig. 1C) to allow for a meaningful comparison. Together, these data
suggest that inflammation enhanced low and high affinity T cell responses equally and
independently of ligand potency. It is important to note that CD4 T cell help is provided
even in the absence of a bystander LM infection since DCs are exposed to antigen (fetal calf
serum, enzymes, etc.) during the isolation process which results in presentation of antigenic
MHC class II restricted epitopes (27, 28).
Integrating inflammation and TCR signals to shape T cell function
We previously demonstrated that priming high affinity CD8 T cells in the context of
minimal inflammation induces robust T cell expansion and IFN-γ production but the cells
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lack granzyme expression and remain KLRG1 low (26). We wanted to determine which
aspects of T cell phenotype and function are regulated primarily by inflammatory stimuli
versus TCR signal strength. We found that production of IFNγ and granzyme B was
enhanced by inflammation, while the affinity of the TCR ligand played only a limited role
(Fig. 2A). In contrast, KLRG1 expression levels were dependent on both, inflammation and
TCR signal strength (Fig. 2A). While inflammation was necessary to induce KLRG1
expression, a greater percentage of cells expressed KLRG1 when stimulated with a high
affinity ligand compared to an intermediate ligand (N4 vs. Q4, about 2x difference). OT-I T
cells that were expanded in the context of systemic inflammation expressed less CD62L on
day 5 post priming regardless of the nature of the ligand (Fig. 2B). Inflammation had very
little impact on the ability of effector cells to produce IL-2, while priming with high affinity
ligand generated cells that produced more IL-2 (Fig. 2A). In contrast, expression of IL-2Rα
(CD25) was directly correlated to both the extent of inflammation present and the strength
of the TCR stimulus on day 5, when both N4 and Q4 primed OT-I T cells had finished
expanding following peptide-pulsed DC immunization (Fig 1C). Together these data show
that TCR signal strength and inflammatory conditions exclusively control certain functional
aspects of the T cell response, while other features are clearly the result of integrating both
signals.
Bim-mediated cell death dictates the size of the effector pool
We wanted to directly address the respective roles of TCR signal strength and inflammatory
signals in regulating effector cell apoptosis and determining the magnitude of the T cell
response. Using the same experimental approach as described in Fig. 1, we primed a 1:1 mix
of WT and bim−/− OT-I cells with high or low affinity ligand pulsed DCs (+/− LM) and
analyzed the magnitude of the OT-I response 5 days later (Fig. 3A). We found that bim-
mediated T cell death does not play a role when high affinity effector cells are primed in the
context of an inflammatory environment (N4+LM) while in the absence of abundant
inflammation high affinity T cells are lost in a bim-dependent manner (N4) (Fig. 3A). The
ratio of bim−/− to WT OT-I T cells is skewed towards the bim−/− cells when primed with
Q4-pulsed DC alone and in contrast to N4 immunization, in this case inflammation was not
sufficient to prevent bim-mediated cell death for low affinity primed T cells (Q4+LM
compared to Q4 only). These data establish a central role for bim in regulating the breadth of
the T cell repertoire and provide a mechanism of how TCR signal strength and inflammation
integrate to determine T cell fate. When peptide pulsed DCs are used for immunization, only
a limited quantity of antigen is provided. This differs from a situation in which a pathogen
expresses antigen, which is available at higher quantities for a longer time-period and with
potentially wider tissue-distribution of the antigen. We therefore next tested the effect of
increasing antigen dose on bim-mediated cell death using the previously described
recombinant strains LM-N4 and LM-Q4 to prime a 1:1 mix of WT and bim−/− OT-I T cells
(Fig. 3B). Strikingly in contrast to immunization with peptide-pulsed DC we found that bim-
mediated cell death did not occur following immunization with recombinant LM strains
even after low affinity (LM-Q4) priming (Fig. 3B). To exclude the possibility that the
different expansion and contraction kinetics of high and low affinity responders may skew
interpretation of the results, we tracked WT and bim−/− OT-I T cells on day 5 and 7 post
priming with LM-N4 and LM-Q4 confirming that bim-dependent cell death of effector cells
during the expansion phase does not play a role in conditions of high dose antigen and
systemic inflammation (Fig 3C). Together these data show that bim-mediated cell death
affects the size of the effector pool through TCR signal strength- and inflammation-
mediated signals, but is overcome when low affinity cells are primed in the context of a
replicating pathogen (Fig. 3D).
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Generating functional memory
We previously demonstrated that high affinity CD8 T cells primed in the context of minimal
inflammation give rise to effector cells that lack granzyme expression, but which contract
normally and give rise to fully functional memory T cells (26). Since inflammation and TCR
signal strength both affected aspects of the CD8 effector phenotype (Fig. 2A), we next tested
the ability of high and low affinity memory cells primed with our without an accompanying
LM infection to respond to a recall response. Specifically, we wanted to address whether
low affinity memory T cells generated in the presence of limited inflammation are actually
functional. OT-I T cells were primed with N4- or Q4-pulsed DCs +/− LM and rested for at
least 30 days. Mice were challenged with a recombinant vaccinia (VAC) or vesicular
stomatitis virus (VSV) expressing OVA. This heterologous rechallenge strategy allowed us
to directly address the recall ability of the memory OT-I T cells without engaging
endogenous, Listeria-specific memory cells. This is important since pre-existing immunity
to a vaccine vector can affect the ensuing memory response to the targeted antigens (29).
Moreover, this secondary response delivers the same quality of stimulus to T cells in all
experimental groups, thus specifically addressing possible differences induced during the
initial T cell priming. Mice were euthanized 5 days after the rechallenge and OT-I T cell
frequency, function and phenotype were determined. We found that both high and low
affinity primed OT-I T cells mounted a robust recall response regardless of the inflammatory
environment during priming (Fig. 4A). This suggests that a low affinity TCR signal
mediated by a limited amount of antigen during the primary response is still sufficient to
generate functional memory T cells. Following VAC-OVA secondary immunization,
progeny of the memory cells were also found in non-lymphoid tissue such as the lung (Fig.
4B) indicating that memory trafficking to non-lymphoid compartments is intact and
independent of the initial TCR signal strength encountered during priming. Most
importantly, this secondary challenge elicited a comparable functional response from all
memory T cells regardless of the priming conditions as measured by IFN-γ and granzyme B
production (Fig. 4C).
Discussion
In the context of vaccine design, generating a broad memory T cell repertoire including high
and low affinity responders is desirable in order to provide a diverse repertoire of
responding memory T cells upon subsequent pathogen encounter. This is thought to be
particularly beneficial for highly variable pathogens such as HIV or influenza. While the
benefits of generating a broad memory T cell repertoire have been established, the
parameters needed to achieve such a response remain poorly defined. We addressed how
inflammatory signals, TCR signal strength (in this context defined as the functional avidity
of a T cell for a given epitope) and antigen dose interact to shape the breadth and function of
an effector and memory T cell response.
We show that inflammation provided by a bystander LM infection enhanced low and high
affinity T cell responses equally and independently of ligand potency when keeping the
antigen dose consistent (Fig. 1). TCR signal strength and inflammatory conditions
exclusively control certain functional aspects of the T cell response, while other features are
clearly the result of integrating both signals (Fig. 2). It is important to keep in mind that
certain functional properties might not change between two ligands of different affinity if an
affinity ceiling is reached (30). However, given the phenotypic and functional differences
that we observed between N4 and Q4 primed OT-I T cells, our data argue against an affinity
threshold model that equally affects all aspects of T cell function. This notion is particularly
interesting when considering that at least certain features of the primary CD8 T cell response
are programmed: brief exposure to high affinity antigen is sufficient to initiate long lasting T
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cell proliferation and induce effector function, however prolonged exposure to antigen
further enhances the magnitude of the response (17, 31–33).
Our study also defines the requirements for preserving low affinity responders in a CD8 T
cell response. Low TCR signal strength and limited inflammation lead to impaired
expansion partially due to bim-dependent apoptosis of low affinity responders (Fig. 3C).
However, a high antigen dose is sufficient to overcome bim-dependent cell death as shown
by the use of recombinant LM strains compared to OT-I cells primed by peptide pulsed DCs
in the presence of an LM infection. We cannot formally exclude the possibility that there is a
concurrent effect on cell division mediated by bim enhancing the difference in WT and
bim−/− T cell accumulation specifically in situations of low affinity stimulation. WT and
bim−/− OT-I T cells have comparable TCR surface expression levels, thus excluding
differential sensitivity of these cells to TCR stimulation (34). An increase in epitope density
has been previously shown to regulate CD8 viability via the Nur77 family member Nor-1
(35). Nor-1 and bim have been proposed to converge at the mitochondrial level to regulate
cell fate in thymic selection (36), but whether similar mechanisms are in place in effector
cells to regulate apoptosis remains to be determined. The difference in cell accumulation in
the LM-N4 and LM-Q4 infected animals could be due to differences in the number of cell
divisions as suggested by BrdU incorporation experiments (4) without a significant role for
bim-mediated apoptosis. Although we cannot measure the fold difference in antigen dose at
different time points following immunization with peptide pulsed DCs versus recombinant
LM, it is important to consider that we are comparing limited versus replicating antigen
scenarios. The number of infected cells in the spleen increases dramatically in the first days
following LM infection (37) and antigen-presentation persists for more than 10 days (38)
supporting our notion that there is a higher antigen availability in the recombinant LM
immunization scenario.
Following a secondary challenge OT-I T cells from all four experimental groups expanded
very robustly, but fold-expansion across the different groups has to be carefully interpreted
due to the different memory precursory frequencies in each group. Importantly, we show
that functional memory cells can be generated in even suboptimal conditions with a limited
antigen dose, low affinity TCR signal and limited inflammation (Fig. 4). Together, our data
provide mechanistic insight into the success of vaccines that are based on using live,
replicating vectors and suggest that this approach is likely the most successful approach to
generate a broad CD8 memory pool.
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Fig. 1. Impact of inflammation and TCR signal strength on the size, function and phenotype of
the primary response
C57BL/6 mice were injected intravenously (i.v.) with 1×106 N4 or Q4 peptide pulsed DCs
and 1×104 naïve OT-I T cells (Thy1.1) with or without an accompanying wild-type Listeria
monocytogenes (LM) infection. The frequency of OT-I T cells of total CD8 T cells (A) in
the blood and (B) in the spleen was determined 5 days later and fold increase of N4 and Q4
primed OT-I T cells (+/− LM) was calculated. Data shown are representative for at least 5
independently performed experiments with a minimum of 3 mice per group. Horizontal bars
represent the mean. (C) The frequency of OT-I T cells in the blood is shown on days 4, 5
and 7 after priming with N4 peptide pulsed DCs + LM and Q4 peptide pulsed DCs + LM.
Data shown are pooled from 2 independently performed experiments with a minimum of 3
mice per group. Statistical significance was determined by student t-test. p-values >0.05
were considered not significant (ns), 0.01 to 0.05 significant (*), 0.001 to 0.01 very
significant (**) and <0.001 extremely significant (***).
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Fig. 2. Impact of inflammation and TCR signal strength on function and phenotype of the
primary response
C57BL/6 mice were injected intravenously (i.v.) with 1×106 N4 or Q4 peptide pulsed DCs
and 1×104 naïve OT-I T cells (Thy1.1) with or without an accompanying LM infection. (A)
OT-I T cell surface phenotype (IL-7Rα, KLRG-1), function (IL-2, IFNγ and granzyme B
expression), (B) CD62L expression and (C) CD25 expression was determined 5 days post
priming. Data are representative of at least 5 independently performed experiments with a
minimum of 3 mice per group.
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Fig. 3. TCR signal strength and inflammation dictate the magnitude of the primary response in a
bim-dependent manner
A mix of 5×103 WT (Thy1.1+) and 5×103 bim−/− CD45.2 OT-I T cells was transferred into
CD45.1+ congenic B6 hosts. (A) Mice were injected intravenously (i.v.) with 1×106 N4 or
Q4 peptide pulsed DCs with or without an accompanying LM infection. Spleens were
harvested 5 days post priming and the ratio of bim−/− to WT OT-I was determined. (B) Mice
were primed with LM-N4 or LM-Q4 and the number of WT and bim−/− OT-I cells in the
spleen was determined on day 7 after infection. (C) Mice were primed with LM-N4 or LM-
Q4. The number of WT and bim−/−OT-I cells in the blood was determined on days 5 and 7
after infection. Data shown are representative for 2–3 independently performed experiments
with a minimum of 3 mice per group. Horizontal bars represent the mean. (D) Overview of
the mechanisms dictating the composition of the T cell response. Low affinity stimulated T
cells are more susceptible to bim-mediated cell death, but this can be partially overcome by
increasing inflammation. Increasing antigen availability in the context of inflammation can
fully overcome the bim-mediated cell death and preserve low affinity T cell responses.
Statistical significance was determined by student t-test. p-values >0.05 were considered not
significant (ns), 0.01 to 0.05 significant (*), 0.001 to 0.01 very significant (**) and <0.001
extremely significant (***).
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Fig. 4. Functional memory is generated even from low affinity T cells primed in an environment
with limited inflammation
(A) More than 30 days after the primary response (as described in Fig. 1), mice of all 4
experimental groups were immunized with recombinant vaccinia virus expressing Ova
(VAC-OVA) and T cell responses in (A) the spleen and (B) lung were determined 5 days
later. (C) Memory cell function was assessed in an in vitro restimulation assay by measuring
IFNγ and granzyme B production. Data shown are representative for 2 independently
performed experiments with a minimum of 3 mice per group. Similar data was obtained
from 2 experiments using recombinant vesicular stomatitis virus (VSV-OVA). Statistical
significance was determined by student t-test. p-values >0.05 were considered not
significant (ns), 0.01 to 0.05 significant (*), 0.001 to 0.01 very significant (**) and <0.001
extremely significant (***).
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